CRT 2024
Coronary
Complex PCI
Session Three [Non-CME]
Itsik Ben-Dor, MD
WHC
MedStar Washington Hospital Center
Washington, District of Columbia, United States
No relationships to disclose
Lowell F. Satler, MD, FSCAI
Director of the Cardiac Cath Lab
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
No relationships to disclose
Rasha Al-Lamee, MA, MD, PhD
Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom
Disclosure(s): Medtronic Vascular: Honoraria (Ongoing)
Gregg W. Stone, MD, FACC, MSCAI
Physician
Mount Sinai
New York, New York, United States
Disclosure information not submitted.
Stephen G. Ellis, MD, FACC, FSCAI
Director of Interventional Cardiology, Senior Academic Officer
Cleveland Clinic
Beachwood, Ohio, United States
No relationships to disclose
Edward Koifman, MD
Director Interventional Cardiology
Meir Medical Center, and Tel Aviv University, Israel
Tel Aviv , Tel Aviv, Israel
Disclosure(s): Abbott Labs: Honoraria (Terminated), Independent Contractor (Terminated); Boston Scientific: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing)
John M. Lasala, MD, PhD, MSCAI
Professor of Medicine; Director, Structural Heart Disease Program
Washington University School of Medicine
St. Louis, Missouri, United States
No relationships to disclose
Michael S. Lee, MD, FACC, FSCAI
Interventional Cardiologist
Southern California Hospital
LOS ANGELES, California, United States
No relationships to disclose
Ayman K. Magd, MD, FSCAI
Professor of Interventional Cardiology
Azhar University
Cairo, Al Qahirah, Egypt
No relationships to disclose
Sa'ar Minha, MD
Director, Interventional Cardiology
Shamir Medical Center
Shoham, Israel
Disclosure(s): Boston Scientific, NovoNordisk, Novartis, Sanofi Aventis, Medtronic, Boehringer Ingelheim, Medison, Abbott, Edwards: Advisor (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer,: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing); Philips: Advisor (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing), Honoraria (Ongoing); Renaly: Advisor (Ongoing), Consultant (Ongoing); Symbiosis: Advisor (Ongoing), Consultant (Ongoing), Stock options (Ongoing)
Tanveer Rab, MD, FACC, FSCAI
Professor
Emory University
Decatur, Georgia, United States
No relationships to disclose
Olga Toleva, MD, MPH
Lead of Advanced Coronary Physiology Program
Georgia Heart Institute
ATLANTA, Georgia, United States
Disclosure(s): No financial relationships to disclose
Poonam Velagapudi, MD
Associate Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska, United States
Disclosure information not submitted.
Robert W. Yeh, MD, MSc
Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
No relationships to disclose